61 related articles for article (PubMed ID: 17368189)
21. Altered corepressor SMRT expression and recruitment to target genes as a mechanism that change the response to androgens in prostate cancer progression.
Godoy AS; Sotomayor PC; Villagran M; Yacoub R; Montecinos VP; McNerney EM; Moser M; Foster BA; Onate SA
Biochem Biophys Res Commun; 2012 Jul; 423(3):564-70. PubMed ID: 22695118
[TBL] [Abstract][Full Text] [Related]
22. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
23. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
Lu X; Farmer P; Rubin J; Nanes MS
J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.
Wietzke JA; Ward EC; Schneider J; Welsh J
Mol Cell Endocrinol; 2005 Jan; 230(1-2):59-68. PubMed ID: 15664452
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms.
Haussler MR; Jurutka PW; Mizwicki M; Norman AW
Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):543-59. PubMed ID: 21872797
[TBL] [Abstract][Full Text] [Related]
26. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
27. LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer.
Battaglia S; Karasik E; Gillard B; Williams J; Winchester T; Moser MT; Smiraglia DJ; Foster BA
Clin Epigenetics; 2017; 9():82. PubMed ID: 28811844
[TBL] [Abstract][Full Text] [Related]
28. VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription.
Singh PK; Long MD; Battaglia S; Hu Q; Liu S; Sucheston-Campbell LE; Campbell MJ
Epigenetics; 2015; 10(1):40-9. PubMed ID: 25494645
[TBL] [Abstract][Full Text] [Related]
29. Anticancer activity of VDR-coregulator inhibitor PS121912.
Sidhu PS; Teske K; Feleke B; Yuan NY; Guthrie ML; Fernstrum GB; Vyas ND; Han L; Preston J; Bogart JW; Silvaggi NR; Cook JM; Singh RK; Bikle DD; Arnold LA
Cancer Chemother Pharmacol; 2014 Oct; 74(4):787-98. PubMed ID: 25107568
[TBL] [Abstract][Full Text] [Related]
30. High levels of PIWI-interacting RNAs are present in the small RNA landscape of prostate epithelium from vitamin D clinical trial specimens.
Baumann B; Lugli G; Gao S; Zenner M; Nonn L
Prostate; 2019 Jun; 79(8):840-855. PubMed ID: 30905091
[TBL] [Abstract][Full Text] [Related]
31. Expression patterns of vitamin D receptor in human prostate.
Krill D; DeFlavia P; Dhir R; Luo J; Becich MJ; Lehman E; Getzenberg RH
J Cell Biochem; 2001; 82(4):566-72. PubMed ID: 11500934
[TBL] [Abstract][Full Text] [Related]
32. Cholesterol synthesis pathway genes in prostate cancer are transcriptionally downregulated when tissue confounding is minimized.
Rye MB; Bertilsson H; Andersen MK; Rise K; Bathen TF; Drabløs F; Tessem MB
BMC Cancer; 2018 Apr; 18(1):478. PubMed ID: 29703166
[TBL] [Abstract][Full Text] [Related]
33. Confirmation of high-throughput screening data and novel mechanistic insights into VDR-xenobiotic interactions by orthogonal assays.
Mahapatra D; Franzosa JA; Roell K; Kuenemann MA; Houck KA; Reif DM; Fourches D; Kullman SW
Sci Rep; 2018 Jun; 8(1):8883. PubMed ID: 29891985
[TBL] [Abstract][Full Text] [Related]
34. Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model.
Giangreco AA; Dambal S; Wagner D; Van der Kwast T; Vieth R; Prins GS; Nonn L
J Steroid Biochem Mol Biol; 2015 Apr; 148():156-65. PubMed ID: 25305352
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment.
Milczarek M; Filip-Psurska B; Swiętnicki W; Kutner A; Wietrzyk J
Oncol Rep; 2014 Aug; 32(2):491-504. PubMed ID: 24919507
[TBL] [Abstract][Full Text] [Related]
36. VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells.
Solomon JD; Heitzer MD; Liu TT; Beumer JH; Parise RA; Normolle DP; Leach DA; Buchanan G; DeFranco DB
Mol Cancer Res; 2014 Aug; 12(8):1166-80. PubMed ID: 24825850
[TBL] [Abstract][Full Text] [Related]
37. Dexamethasone enhances 1alpha,25-dihydroxyvitamin D3 effects by increasing vitamin D receptor transcription.
Hidalgo AA; Deeb KK; Pike JW; Johnson CS; Trump DL
J Biol Chem; 2011 Oct; 286(42):36228-37. PubMed ID: 21868377
[TBL] [Abstract][Full Text] [Related]
38. Tumor progression in the LPB-Tag transgenic model of prostate cancer is altered by vitamin D receptor and serum testosterone status.
Mordan-McCombs S; Brown T; Wang WL; Gaupel AC; Welsh J; Tenniswood M
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):368-71. PubMed ID: 20347977
[TBL] [Abstract][Full Text] [Related]
39. Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial.
Fedirko V; Bostick RM; Long Q; Flanders WD; McCullough ML; Sidelnikov E; Daniel CR; Rutherford RE; Shaukat A
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):280-91. PubMed ID: 20056649
[TBL] [Abstract][Full Text] [Related]
40. An enhancer 20 kilobases upstream of the human receptor activator of nuclear factor-kappaB ligand gene mediates dominant activation by 1,25-dihydroxyvitamin D3.
Nerenz RD; Martowicz ML; Pike JW
Mol Endocrinol; 2008 May; 22(5):1044-56. PubMed ID: 18202151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
